Balance Study on ICU-acquired Hypernatremia and Sodium Handling (BIAS) (BIAS)
Balance Study on ICU-acquired Hypernatremia and Sodium Handling
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Leeuwarden, Netherlands
- Medisch Centrum Leeuwarden
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Predicted duration of ICU-admission >48 hours
Exclusion Criteria:
- Renal replacement therapy
- Reason for admission necessitates actively elevation of serum sodium concentration
- Electrolyte disturbance as reason for admission
- ICU re-admission within 30 days
- Referral from another ICU
- Serum sodium concentration on admission 143mmol/l or above
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sodium balance
Time Frame: During ICU-admission
|
Differences in sodium balances between patients who do and do not develop IAH
|
During ICU-admission
|
|
Fluid balance
Time Frame: During ICU-admission
|
Differences in fluid balances between patients who do and do not develop IAH
|
During ICU-admission
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Kidney function
Time Frame: During ICU-admission
|
Differences in parameters concerning kidney function (creatinine, urea) between patients who do and do not develop IAH
|
During ICU-admission
|
|
Inflammation
Time Frame: During ICU-admission
|
Differences in inflammation (CRP, infections) between patients who do and do not develop IAH
|
During ICU-admission
|
|
Nutritional state
Time Frame: During ICU-admission
|
Differences in nutritional state (albumin, BIVA-measurement) between patients who do and do not develop IAH
|
During ICU-admission
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Christiaan Boerma, Medical center Leeuwarden
Publications and helpful links
General Publications
- Darmon M, Diconne E, Souweine B, Ruckly S, Adrie C, Azoulay E, Clec'h C, Garrouste-Orgeas M, Schwebel C, Goldgran-Toledano D, Khallel H, Dumenil AS, Jamali S, Cheval C, Allaouchiche B, Zeni F, Timsit JF. Prognostic consequences of borderline dysnatremia: pay attention to minimal serum sodium change. Crit Care. 2013 Jan 21;17(1):R12. doi: 10.1186/cc11937.
- van IJzendoorn MC, Buter H, Kingma WP, Navis GJ, Boerma EC. The Development of Intensive Care Unit Acquired Hypernatremia Is Not Explained by Sodium Overload or Water Deficit: A Retrospective Cohort Study on Water Balance and Sodium Handling. Crit Care Res Pract. 2016;2016:9571583. doi: 10.1155/2016/9571583. Epub 2016 Sep 14.
- Bihari S, Ou J, Holt AW, Bersten AD. Inadvertent sodium loading in critically ill patients. Crit Care Resusc. 2012 Mar;14(1):33-7.
Study record dates
Study Major Dates
Study Start (ACTUAL)
Study Start
Primary Completion (ACTUAL)
Primary Completion
Study Completion (ACTUAL)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ACTUAL)
First Posted
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- ZRTPO 996
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.